In models of hepatitis B virus–related hepatocellular carcinoma (40) and in sarcoma cell lines (48), classical NFKB signaling (RELA) controls metabolic substrate preference in favor of glycolysis through transcriptional upregulation of HK2. Here, HK2 is linked to hepatocellular carcinoma.